The N-FIS® (Needle-Free Injection System) is a patented medical device developed by IntegriMedical designed to deliver medications and vaccines without the use of a conventional hypodermic needle. It uses high-pressure jet technology to propel liquid drugs through a micro-orifice directly into the skin.
- Jet Stream Delivery: The system utilizes a high-pressured, spring-driven stainless-steel piston to create a fine liquid jet stream that passes through a 0.15 mm micro-orifice.
- Administration Routes: It is capable of delivering medications via Subcutaneous (SC) and Intramuscular (IM) routes.
Key Benefits
- Pain Reduction: Clinical trials indicate significantly lower pain scores (mean VAS score 0.23) compared to traditional needles (1.07), with 90% of patients reporting zero pain.
- Safety: Eliminates the risk of needle-stick injuries and cross-contamination, which are major concerns for healthcare workers.
- Patient Compliance: Specifically targets “needle phobia” (trypanophobia), making it ideal for pediatric care and patients requiring frequent injections (e.g., hormone therapy or IVF).
- Environmental Impact: Reduces toxic sharps waste by eliminating the disposal of used metal needles
Manufacturer: IntegriMedical
Addresses:
- India:
- Survey No. 614, Hissa No. 10 & 11, At Post Saswad, Taluka Purandhar, Pune, Maharashtra 412301, India
- Phone: +91 727 621 2555 or +91 83809 00981
- United States
- Address: 7862 N County Road 100 E, Bainbridge, IN 46105, USA
- Phone: +1 (765) 721 4933
- Europe:
- Address: 1163 Budapest, Cziráki u 26-32, Hungary
- Phone: +(852) 2498 9511
Product Prices
Cost per Injection: In India, the price for a single administration using N-FIS at a doctor’s clinic typically ranges between ₹300 and ₹500 ($3.50 – $6.00 USD).
Comparison: This is considered a premium service compared to traditional needle-based vaccinations, which generally cost around ₹50 ($0.60 USD).
Home Use: While primarily used in clinics, kits for home use (often for chronic conditions like growth hormone therapy or IVF) are described as being priced in the “lower hundreds, not thousands” of dollars to encourage adoption.
Free References
Comparative Immunogenicity and Safety of Measles-Mumps-Rubella Vaccine When Administered Using Needle Free Injection System to That with Conventional Needle-Syringe in India: A Randomized, Parallel Group Study
Pilot Study on Safety & Acceptability of IntegriMedical® Needle-Free vs. Needle Injection Using Saline
Leave a Reply